0IGA.LSE Emergent Biosolutions Inc.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
1.9x
P/B
-
ROE
-101.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0IGA.LSE undervalued?

Graham number

The Graham number of Emergent Biosolutions Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Emergent Biosolutions Inc. fundamental analysis

No fundamental analysis for Emergent Biosolutions Inc. yet.

Emergent Biosolutions Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Emergent Biosolutions Inc.

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhala…

Full company profile